CLINICAL_TRIALS
research
· 2026-04-03
Clinical Trial Update: Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories [Phase 2]
Summary
A Phase 2 clinical trial sponsored by Massachusetts General Hospital is evaluating spironolactone to improve trajectories in pregnancy-associated hypertension a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Preeclampsia, Gestational Hypertension | Phase 2 | Status: RECRUITING